In this study, we comprehensively investigated the expression level, mutations, diagnostic and prognostic significance of H2AFY in patients with HCC in various public databases, including Oncomine, HCCDB, The Cancer Genome Atlas (TCGA), International Cancer Genome Consortium (ICGC) and others. The gene discussed is MACROH2A1; the disease is hepatocellular carcinoma.